Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell lines

Expression of the protease sensing receptor, protease activated receptor-2 (PAR2), is elevated in a variety of cancers and has been promoted as a potential therapeutic target. With the development of potent antagonists for this receptor, we hypothesised that they could be used to treat renal cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Morais, Christudas, Rajandram, Retnagowri, Blakeney, Jade S., Iyer, Abishek, Suen, Jacky Y., Johnson, David W., Gobe, Glenda C., Fairlie, David P., Vesey, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993771/
https://www.ncbi.nlm.nih.gov/pubmed/33765016
http://dx.doi.org/10.1371/journal.pone.0248983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993771/
https://www.ncbi.nlm.nih.gov/pubmed/33765016
http://dx.doi.org/10.1371/journal.pone.0248983

Ejemplares similares